POSTERS ASCO 2024

Cáncer de cabeza y cuello

Sacituzumab govitecan in patients with advanced or metastatic radioactive-iodine refractory thyroid carcinoma: The phase 2 SETHY, GETNE-T2318 trial.

Sacituzumab govitecan in patients with advanced or metastatic radioactive-iodine refractory thyroid carcinoma: The phase 2 SETHY, GETNE-T2318 trial.

Abstract: TPS6130 Poster Bd #: 437b

Poster

Descargar

Autor
Alejandro García-Álvarez, MD

Medical Oncology Department. Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO)

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON